Cryo Cell International (CCEL) Cash from Investing Activities (2010 - 2026)

Cryo Cell International has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $19104.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 106.65% year-over-year to $19104.0; the TTM figure through Feb 2026 stood at -$668744.0 (up 86.14% YoY), while the FY2025 annual figure was -$975332.0, up 80.0% from the prior year.
• Cash from Investing Activities climbed to $19104.0 in Q1 2026, from -$289649.0 in the prior quarter.
• Over the last five years, Cash from Investing Activities for CCEL reached as high as $1.9 million in Q4 2022 and fell as low as -$11.2 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is -$1.1 million (2024), against an average of -$1.7 million.
• The widest YoY moves for Cash from Investing Activities: up 758.4% in 2022, down 3637.07% in 2022.
• A 5-year view of Cash from Investing Activities shows it stood at $1.9 million in 2022, then tumbled by 203.45% to -$2.0 million in 2023, then soared by 43.7% to -$1.1 million in 2024, then surged by 74.04% to -$289649.0 in 2025, then jumped by 106.6% to $19104.0 in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $19104.0, -$289649.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.